Harbour Investments’s Roivant Sciences ROIV Stock Holding History

Harbour Investments’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.68K	Buy	104 +37	+55%	+$1.09K	﹤0.01%	3812
2026 Q1	$1.86K	Sell	67 -299	-82%	-$7.68K	﹤0.01%	3927
2025 Q4	$7.94K	Buy	+366	New	+$7.22K	﹤0.01%	2850
2024 Q3	–	Sell	-1,000	Closed	-$10.6K	–	3465
2024 Q2	$10.6K	Hold	1,000	–	–	﹤0.01%	2241
2024 Q1	$10.5K	Hold	1,000	–	–	﹤0.01%	2204
2023 Q4	$11.2K	Hold	1,000	–	–	﹤0.01%	2099
2023 Q3	$11.7K	Buy	+1,000	New	+$11.3K	﹤0.01%	1977

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Harbour Investments's ROIV Position: Q2 2026 in Review

Harbour Investments increased its Roivant Sciences (ROIV) stake by 55% in Q2 2026, buying an estimated $1.09K and bringing the position to 104 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

Harbour Investments first reported a position in ROIV in Q3 2023 and has held it in 7 quarters since. The position peaked at $11.7K in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Harbour Investments held 104 shares of Roivant Sciences worth $3.68K as of Q2 2026.
Harbour Investments bought 37 Roivant Sciences shares in Q2 2026, an estimated $1.09K.
Roivant Sciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3812 holding.
Harbour Investments first reported a position in Roivant Sciences in Q3 2023 and has held it in 7 quarters since.
Harbour Investments's Roivant Sciences position peaked at $11.7K in Q3 2023.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.